BioVaxys Reports Positive Clinical Study Results from Phase 1B/2 PESCO Trial of MVP-S with Pembrolizumab (Keytruda (TM)) and Low-Dose Cyclophosphamide for Patients with ...

Study subject Remains in Complete Response for 3 YearsExceeds Expectations in Platinum-Resistant Ovarian Cancer Compared to Standard of Care Single-Agent ChemotherapyVancouver, British ...
EuropaWire

Jake Morris Takes Leadership of ZF’s UK R&D Hub as Group Advances Mobility Technologies

ZF Group has appointed Jake Morris as Site Leader of its UK Research and Development Hub in Solihull, effective January 1, 2026. With more than 25 years at ZF, Morris brings deep experience in ...
EuropaWire

cortAIx Germany Strengthens Thales’ Global Push for Sovereign and Resilient AI

Thales has opened a new cortAIx AI accelerator site in Germany, expanding its global network to five locations and reinforcing its focus on trustworthy AI for critical defence and security systems.